Features Screener Stocks Charts
Sign In Sign Up

Piramal Enterprises Income Statement

NSE:PEL | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year PEL income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 101.78B 106.12B
Cost of Revenue -565.30M -355.10M
Gross Profit 101.22B 105.76B
Sales, General & Admin -28.83B -28.01B
Operating Income 29.98B 62.01B
Profit Before Tax -32.78B 6.45B
Net Income -16.84B 4.85B
Diluted Shares 232.97M 227.56M
Diluted EPS -72.82 21.33

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025